Inhibition of primary murine macrophage cytokine production in vitro following treatment with the K-opioid agonist U50,488H

Journal of Neuroimmunology

Volumn 64, Issue 1, 1996, Pages 83-90

  Alicea, Candido ^a   Belkowski, Stanley ^a   Eisenstein, Toby K ^a   Adler, Martin W ^a   Rogers, Thomas J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunosuppression; Interleukins; K opioid receptors; U50,488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; INTERLEUKIN 1; INTERLEUKIN 6; KAPPA OPIATE RECEPTOR; LIPOPOLYSACCHARIDE; NALOXONE; NORBINALTORPHIMINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; CELL LINE; CYTOKINES; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NALOXONE; PYRROLIDINES; RECEPTORS, OPIOID, KAPPA;

EID: 0030019450     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(95)00159-X     Document Type: Article

References (28)

1. Apte, R.N., Durum, S.K. and Oppenheim, J.J. (1990) Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages. Immunol. Lett. 24, 141-148.
2. Ausiello, C.M. and Roda, G. (1984) Leu-enkephalin binding to cultured human T lymphocytes. Cell. Biol. Int. Rep. 8, 353-362.
3. Bayer, B.M., Daussin, S., Hemandez, M. and Irvin, L. (1990) Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 29, 369-374.
4. Bessler, H., Sztein, M.B. and Serrate, S.A. (1990) ß-Endorphin modulation of IL-1-induced IL-2 production. Immunopharmacology 19, 5-14.
5. Bidlack, J.M., Saripalli, L.D. and Lawrence, D.M.P. (1992) K-Opioid binding sites on a murine lymphoma cell line. Eur. J. Pharm. Mol. Pharm. Sec. 277, 257-265.
6. Brown, S.L. and Van Epps, D.E. (1986) Opioid peptides modulate production of interferon-gamma by human mononuclear cells. Cell. Immunol. 103, 19-26.
7. Brown, S.M., Stimmel, B., Taub, R.N., Kochwa, S. and Rosenfield, R.E. (1974) Immunologic dysfunction in heroin addicts. Arch. Intern. Med. 134, 1001-1006.
8. Bryant, H.U. and Roudebush, R.E. (1990) Suppressive effects of morphine pellet implants on in vivo parameters of immune function. J. Pharmacol. Exp. Ther. 255, 410-414.
9. j (Beige) mice. Life Sci. 52, 43-48.
10. Bussiere, J.L., Adler, M.W., Rogers, T.J. and Eisenstein, T.K. (1992b) Differential effects of morphine and naltrexone on the antibody response in various mouse strains. Immunopharmacol. Immunotoxicol. 14, 657-693.
11. Bussiere, J.L., Adler, M.W., Rogers, T.J. and Eisenstein, T.K. (1993) Cytokine reversal of morphine-induced suppression of the antibody response. J. Pharmacol. Exp. Ther. 264, 591-597.
12. Carr, D.J.J., Kim, C.-H., DeCosta, B.R., Jacobson, A.E., Rice, K.C. and Blalock, J.E. (1988) Evidence for a δ-class opioid receptor on cells of the immune system. Cell. Immunol. 116, 44-51.
13. Carr, D.J.J., DeCosta, B.R., Kim, C.-H., Jacobson, A.E., Guarcello, V., Rice, K.C. and Blalock, J.E. (1989) Opioid receptors on cells of the immune system: evidence for δ- and K-classes. J. Endocrinol. 122, 161-168.
14. Carr, D.J.J., DeCosta, B.R., Jacobson, A.E., Rice, K.C. and Blalock, J.E. (1991) Enantioselective kappa opioid binding sites on the macrophage cell line, P388d, Life Sci. 49, 45-51.
15. Carr, D.J.J., Gebhardt, B.M. and Paul, D. (1993) Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J. Pharmacol. Exp. Ther. 264, 1179-1186.
16. Casellas, A.M., Guardiola, H. and Renaud, F.L. (1991) Inhibition by opioids of phagocytosis in peritoneal macrophages. Neuropeptides 18, 35-40.
17. Cherubin, C.E. (1967) The medical sequelae of narcotic addiction. Ann. Intern. Med. 67, 23-33.
18. Eisenstein, T.K., Meissler, J.J. Jr., Geller, E.B. and Adler, M.W. (1990) Immunosuppression to tetanus toxoid induced by implanted morphine pellets. In: M.S. O'Dorisio and A. Panerai (Eds.), Proceedings of the New York Academy of Sciences, Neuropeptides and Immunopeptides: Messengers in a Neuroimmune Axis. New York Academy of Sciences, New York, NY, pp. 373-379.
19. Faith, R.E., Liang, HJ., Murgo, AJ. and Plotnikoff, N.P. (1984) Neuroimmunomodulation with enkephalins: enhancement of human natural killer (NK) cell activity in vitro. Clin. Immunol. Immunopathol. 31, 412-418.
20. Fiorica, E. and Spector, S. (1988) Opioid binding site in EL-4 thymoma cell line. Life Sci. 42, 199-206.
21. Fischer, E.G. (1988) Opioid peptides modulate immune function. A review. Immunopharmacol. Immunotoxicol. 10, 265-326.
22. Foris, G., Medgyesi, A., Gyimesi, E. and Hauck, M. (1984) Met-enkephalin induced alterations of macrophage functions. Mol. Immunol. 21, 747-750.
23. Foris, G., Medgyesi, G.A. and Hauk, M. (1986) Bidirectional effect of met-enkephalin on macrophage effector functions. Mol. Cell. Biochem. 69, 127-137.
24. Gabrilovac, J., Martin-Kleiner, I., Ikic-Sutlic, M. and Osmak, M. (1992) Interaction of leu-enkephalin and α-interferon in modulation of NK-activity of human peripheral blood lymphocytes. Ann. N.Y. Acad. Sci. 650, 140-145.
25. Oilman, S.C., Schwartz, J.M., Milner, R.J., Bloom, F.E. and Feldman, J.D. (1982) ß-Endorphin enhances lymphocyte proliferative responses. Proc. Natl. Acad. Sci. USA 79, 4226-4230.
26. Gilmore, W. and Weiner, L.P. (1989) The opioid specificity of beta-endorphin enhancement of murine lymphocyte proliferation. Immunopharmacology 17, 19-30.
27. Gilmore, W., Moloney, M. and Berinstein, T. (1990) The enhancement of polyclonal T cell proliferation by beta-endorphin. Brain Res. Bull. 24, 687-692.
28. Guan, L., Townsend, R., Eisenstein, T.K., Adler, M.W. and Rogers, T.J. (1994) Both T cells and macrophages are targets of K-opioid-induced immunosuppression. Brain Behav. Immun. 8, 229-240.